obsessive-compulsive disorder, tic disorders, Tourette disorder, psychopharmacology
Digital Object Identifier (DOI)
In recent years, much progress has been made in pharmacotherapy for pediatric obsessive-compulsive disorder (OCD) and chronic tic disorders (CTDs). What were previously considered relatively intractable conditions now have an array of efficacious medicinal (and psychosocial) interventions available at clinicians' disposal, including selective serotonin reuptake inhibitors, atypical antipsychotics, and alpha-2 agonists. The purpose of this review is to discuss the evidence base for pharmacotherapy with pediatric OCD and CTDs with regard to efficacy, tolerability, and safety, and to put this evidence in the context of clinical management in integrated behavioral healthcare. While there is no single panacea for these disorders, there are a variety of medications that provide considerable relief for children with these disabling conditions.
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License
Was this content written or created while at USF?
Citation / Publisher Attribution
Journal of Central Nervous System Disease, v. 3, p. 125-142
Scholar Commons Citation
De Nadai, Alessandro S.; Storch, Eric A.; Mcguire, Joseph F.; Lewin, Adam B.; and Murphy, Tanya K., "Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders" (2011). Psychology Faculty Publications. 2446.